← Eichor
Condition: Daytime Sleepiness Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Daytime Sleepiness

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Bright Light Therapy for OSA
NA · 1 location(s) · VA Office of Research and Development · NCT05917119Morning Bright Light Therapy and Daytime Functioning in University Students
NA · 1 location(s) · The Hong Kong Polytechnic University · NCT07685262A Study Assessing Adult Patients Referred to an NHS Sleep Service With Suspected Obstructive Sleep Apnoea. This Study Ai
NA · 1 location(s) · Virginia Hawkins · NCT07269483A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central
Phase 2/Phase 3 · 7 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07598708A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 2 · 24 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07096674Sleep and Stroke Rehabilitation Study
Phase N/A · 1 location(s) · Malin Eleonora av Kák Gustafsson, MD, PhD · NCT07579871A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Phase 3 · 22 location(s) · Harmony Biosciences Management, Inc. · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Phase 3 · 22 location(s) · Alkermes, Inc. · NCT07455383A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Phase 2/Phase 3 · 46 location(s) · Alkermes, Inc. · NCT06767683A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1
Phase 3 · 10 location(s) · Alkermes, Inc. · NCT07540897Spanish Registry of Patients With Sleep Apnea and Daytime Sleepiness
Phase N/A · 1 location(s) · Hospital San Pedro de Logroño · NCT06514482A Study of Pitolisant in Patients With Prader-Willi Syndrome
Phase 3 · 54 location(s) · Harmony Biosciences Management, Inc. · NCT06366464A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Phase 3 · 19 location(s) · Alkermes, Inc. · NCT07502443Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression
NA · 1 location(s) · Jakub Antczak · NCT06371352A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Phase 1 · 3 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07082829Impact of Bright Light Therapy on Prader-Willi Syndrome
NA · 1 location(s) · Maimonides Medical Center · NCT05939453Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Phase 3 · 40 location(s) · Axsome Therapeutics, Inc. · NCT07484217Effect of Inspiratory Muscle Training in Obstructive Sleep Apnea Syndrome.
NA · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT06117579Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal
NA · 1 location(s) · Stefan Lakämper · NCT06872593Digital Sleep Program for College Students with Insomnia
NA · 1 location(s) · Taipei Medical University · NCT06853106A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
Phase 2 · 50 location(s) · Alkermes, Inc. · NCT06843590Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
Phase 2 · 1 location(s) · Johns Hopkins University · NCT06170970Promoting Teenage Sleep for Improved Mental Health and School Performance
NA · 1 location(s) · Kristianstad University · NCT06306092Sleep and Morning Wellbeing Study
NA · 1 location(s) · Athletic Greens International · NCT07311434SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorativ
Phase N/A · 1 location(s) · Zealand University Hospital · NCT06711159
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.